CIK 0001372299 · Non-accelerated filer<br>Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,088,801
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,088,801. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-03 | Kompella Uday Director | Sale | −25,000 | $14.00 | $350K | 575,674 |
| 2021-05-03 | Kompella Uday Director | Sale | −25,000 | $16.02 | $401K | 550,674 |
| 2021-05-03 | Musunuri Shankar Chief Executive Officer | Option exercise | +195,809 | $0.51 | $100K | 601,809 |
| 2021-05-03 | Musunuri Shankar Chief Executive Officer | Sale | −195,809 | $14.24 | $2.8M | 406,000 |
| 2021-05-03 | Musunuri Shankar Chief Executive Officer | Option exercise · Options (Right to Buy) | −195,809 | 737,719 | ||
| 2021-05-03 | Tammara Vijay Senior Vice President | Option exercise | +4,317 | $0.46 | $2K | 4,317 |
| 2021-05-03 | Tammara Vijay Senior Vice President | Sale | −4,317 | $16.00 | $69K | 0 |
| 2021-05-03 | Tammara Vijay Senior Vice President | Option exercise · Options (Right to Buy) | −4,317 | 4,900 | ||
| 2021-04-30 | Kompella Uday Director | Option exercise | +20,000 | $0.51 | $10K | 620,674 |
| 2021-04-30 | Kompella Uday Director | Sale | −20,000 | $11.56 | $231K | 600,674 |
| 2021-04-30 | Kompella Uday Director | Option exercise · Option (right to buy) | −20,000 | 34,000 | ||
| 2021-04-29 | Subramanian Sanjay Chief Financial Officer | Option exercise | +7,990 | $2.19 | $17K | 53,581 |
| 2021-04-29 | Subramanian Sanjay Chief Financial Officer | Sale | −7,990 | $10.98 | $88K | 45,591 |
| 2021-04-29 | Subramanian Sanjay Chief Financial Officer | Option exercise · Option (Right to Buy) | −7,990 | 15,980 | ||
| 2021-04-29 | Tammara Vijay Senior Vice President | Option exercise | +9,000 | $0.46 | $4K | 9,000 |
| 2021-04-29 | Tammara Vijay Senior Vice President | Sale | −9,000 | $10.97 | $99K | 0 |
| 2021-04-29 | Tammara Vijay Senior Vice President | Option exercise | +3,000 | $2.94 | $9K | 3,000 |
| 2021-04-29 | Tammara Vijay Senior Vice President | Sale | −3,000 | $10.99 | $33K | 0 |
| 2021-04-29 | Tammara Vijay Senior Vice President | Option exercise | +12,880 | $0.51 | $7K | 12,880 |
| 2021-04-29 | Tammara Vijay Senior Vice President | Sale | −12,880 | $10.96 | $141K | 0 |
Page 12 of 27 · 525 trades